Response to lithium in bipolar disorder: Clinical and genetic findings

ACS Chemical Neuroscience

Volumn 5, Issue 6, 2014, Pages 413-421

  Rybakowski, Janusz K ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

bipolar disorder; clinical factors; efficacy; genetic factors; Lithium

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GELATINASE B; LITHIUM DERIVATIVE; MOOD STABILIZER; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; NEUROLEPTIC AGENT;

BIPOLAR DISORDER; CIRCADIAN RHYTHM; COGNITION; DEPRESSION; DRUG EFFICACY; ENDOPHENOTYPE; FOLLOW UP; GENETIC ASSOCIATION; HEREDITY; HUMAN; HYPOMANIA; INTRACELLULAR SIGNALING; NEUROPROTECTION; NEUROTRANSMISSION; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE; DRUG RESISTANCE; GENETICS;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; DRUG RESISTANCE; HUMANS; LITHIUM COMPOUNDS;

EID: 84902657383     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn5000277     Document Type: Review

References (100)

1. Merinkangas, K. R. and Tohen, M. (2011) Epidemiology of bipolar disorder in adults and children. In Textbook in Psychiatric Epidemiology (Tsuang, M. T., Tohen, M. T., and Jones, P. B., Eds.), pp 329-342, John Wiley and Sons, Chichester, UK.
2. Rihmer, Z. and Kiss, K. (2002) Bipolar disorders and suicidal behavior Bipolar Disord. 4 (Suppl 1) 21-25
3. American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders, fifth ed., DSM-5. American Psychiatric Association, Arlington, VA.
4. Cade, J. F. (1949) Lithium salts in the treatment of psychotic excitement Med. J. Aust. 2, 349-352
5. Hartigan, G. (1963) The use of lithium salts in affective disorders Br. J. Psychiatry 109, 810-814
6. Schou, M. and Thompsen, K. (1976) Lithium prophylaxis of recurrent endogenous affective disorders. In Lithium Research and Therapy (Johnson, F. N., Ed.), pp 63-84, Academic Press, London.
7. Geddes, J. R., Burgess, S., Kawton, K., Jamison, K., and Goodwin, G. M. (2004) Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials Am. J. Psychiatry 161, 217-222
8. Nivoli, A. M. A., Murru, A., and Vieta, E. (2010) Lithium: still a cornerstone in the long-term treatment in bipolar disorder? Neuropsychobiology 62, 27-35
9. Rybakowski, J. K. (2011) Lithium in neuropsychiatry: A 2010 update World J. Biol. Psychiatry 12, 340-348
10. Grof, P. (1999) Excellent lithium responders: people whose lives have been changed by lithium prophylaxis. In Lithium: 50 Years of Psychopharmacology, New Perspectives in Biomedical and Clinical Research (Birch, N. J., Gallicchio, V. S., and Becker, R. W., Eds.), pp 36-51, Weidner Publishing Group, Cheshire, CT.
11. Rybakowski, J. K., Chlopocka-Wozniak, M., and Suwalska, A. (2001) The prophylactic effect of long-term lithium administration in bipolar patients entering lithium treatment in the 1970s and 1980s Bipolar Disord. 3, 63-67
12. Grof, P., Duffy, A., Cavazzoni, P., Grof, E., Garnham, J., MacDougall, M., O'Donovan, C., and Alda, M. (2002) Is response to prophylactic lithium a familial trait? J. Clin. Psychiatry 63, 942-947
13. Post, R. (2012) Acquired lithium resistance revisited: Discontinuation-induced refractoriness versus tolerance J Affective Disord. 140, 6-13
14. Berghöfer, A., Alda, M., Adli, M., Baethge, C., Bauer, M., Bschor, T., Grof, P., Müller-Oerlinghausen, B., Rybakowski, J. K., Suwalska, A., and Pfennig, A. (2013) Stability of lithium treatment in bipolar disorder-long-term follow-up of 346 patients Int. J. Bipolar Disord. 1, 11
15. Grof, P. (2010) Sixty years of lithium responders Neuropsychobiology 62, 27-35
16. Kraepelin, E. (1899) Psychiatrie. Ein Lehrbuch für Studierende und Ärzte. 6 Auflage. Barth, Leipzig.
17. Kleindienst, N., Engel, R. R., and Greil, W. (2005) Which clinical factors predict response to prophylactic lithium? A systematic review for bipolar disorders Bipolar Disord. 7, 404-417
18. Kleindienst, N. and Greil, W. (2000) Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study Neuropsychobiol 42 (Suppl 1) 2-10
19. Passmore, M. J., Garnham, J., Duffy, A., MacDougall, M., Munro, A., Slaney, C., Teehan, A., and Alda, M. (2003) Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine Bipolar Disord. 5, 110-114
20. Kliwicki, S., Chlopocka-Wozniak, M., Rudnicka, E., and Rybakowski, J. (2014). Efficacy of long-term lithium treatment in bipolar disorder (in Polish). Pharmacother. Psychiatry Neurol. 30 (in press).
21. Franchini, L., Zanardi, B., Smeraldi, E., and Gasperani, M. (1999) Early onset of lithium prophylaxis as a predictor of good longterm outcome Eur. Arch. Psychiatry Neurol. Sci. 249, 227-230
22. Ketter, T. A., Houston, J. P., Adams, D. H., Risser, R. C., Meyers, A. L., Williamson, D. J., and Tohen, M. (2006) Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes J. Clin. Psychiatry 67, 95-101
23. Maj, M., Arena, F., Lovero, N., Pirozzi, R., and Kemali, D. (1985) Factors associated with response to lithium prophylaxis in DSM III major depression and bipolar disorder Pharmacopsychiatry 18, 309-313
24. Mendlewicz, J., Fieve, R. R., and Stallone, F. (1973) Relationship between the effectiveness of lithium therapy and family history Am. J. Psychiatry 130, 1011-1013
25. Coryell, W., Akskal, H., Leon, A. C., Turvey, C., Solomon, D., and Endicott, J. (2000) Family history and symptom levels during treatment for bipolar I affective disorder Biol. Psychiatry 47, 1034-1042
26. Misra, P. C. and Burns, B. H. (1977) "Lithium non-responders" in a lithium clinic Acta Psychiatr. Scand. 55, 32-40
27. Young, L. T., Cooke, R. G., Robb, J. C., Levitt, A. J., and Joffe, R. T. (1993) Anxious and non-anxious bipolar disorder J. Affective Disord. 29, 49-52
28. O'Connell, R. A., Mayo, J. A., Flatow, L., Cuthbertson, B., and O'Brien, B. E. (1991) Outcome of bipolar disorder on long-term treatment with lithium Br. J. Psychiatry 159, 123-129
29. Akiskal, H. S., Akiskal, K. K., Haykal, R. F., Manning, J. S., and Connor, P. D. (2005) TEMPS-A: progress towards validation of a self-rated clinical version of the Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego Autoquestionnaire J. Affective Disord. 85, 3-16
30. Mason, O. and Claridge, G. (2006) The Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE): Further description and extended norms Schizophr. Res. 82, 203-211
31. Rybakowski, J. K., Dembinska, D., Kliwicki, S., Akiskal, K. K., and Akiskal, H. S. (2013) TEMPS-A and long-term lithium response: Positive correlation with hyperthymic temperament J. Affective Disord. 145, 187-189
32. Perugi, G., Maremmani, I., Toni, C., Madaro, D., Mata, B., and Akiskal, H. S. (2001) The contrasting influence on depressive and hyperthymic temperaments on psychometrically derived manic subtypes Psychiatry Res. 101, 249-258
33. Dembinska-Krajewska, D., Kliwicki, S., Chlopocka-Wozniak, M., and Rybakowski, J. (2012) Efficacy of prophylactic lithium administration in bipolar affective illness and schizotypic traits (in Polish) Pharmacother. Psychiatry Neurol. 28, 153-158
34. Schurhoff, F., Laguerre, A., Szoke, A., Meary, A., and Leboyer, M. (2005) Schizotypal dimensions: continuity between schizophrenia and bipolar disorders Schizophr. Res. 80, 235-42
35. Cruceanu, C., Alda, M., and Turecki, G. (2009) Lithium: a key to the genetics of bipolar disorder Genome Med. 1, 79.1-79.7
36. McCarthy, M. J., Leckband, S. G., and Kelsoe, J. R. (2010) Pharmacogenetics of lithium response in bipolar disorder Pharmacogenomics 11, 1439-1465
37. Smith, D. J., Evans, R., and Craddock, N. (2010) Predicting response to lithium in bipolar disorder: A critical review of pharmacogenetic studies J. Ment. Health 19, 142-156
38. Serretti, A. and Drago, A. (2010) Pharmacogenetics of lithium long-term treatment: focus on initiation and adaptation mechanisms Neuropsychobiol. 62, 61-71
39. Rybakowski, J. K. (2013) Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge CNS Drugs 27, 165-173
40. Müller-Oerlinghausen, B. (1985) Lithium long-term treatment-does it act via serotonin? Pharmacopsychiatry 18, 214-217
41. Hauser, J., Leszczynska, A., Samochowiec, J., Czerski, P. M., Ostapowicz, A., Chlopocka, M., Horodnicki, J., and Rybakowski, J. K. (2003) Association analysis of the insertion/deletion polymorphism in serotonin transporter gene in patients with affective disorder Eur. Psychiatry 18, 129-132
42. Porcelli, S., Fabbri, C., and Serretti, A. (2012) Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy Eur. Neuropsychopharmacol. 22, 239-258
43. Serretti, A., Lilli, R., Mandelli, L., Lorenzi, C., and Smeraldi (2001) Serotonin transporter gene associated with lithium prophylaxis in mood disorders Pharmacogenomics J. 1, 71-77
44. Serretti, A., Malitas, P. N., and Mandelli, L. (2004) Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders Pharmacogenomics J. 4, 267-273
45. Rybakowski, J. K., Suwalska, A., Czerski, P. M., Dmitrzak-Weglarz, M., Leszczynska-Rodziewicz, A., and Hauser, J. (2005) Prophylactic effect of lithium in bipolar affective illness may be related to serotonin transporter genotype Pharmacol. Rep. 57, 124-127
46. Michelon, L., Meira-Lima, I., Cordeiro, Q., Miguita, K., Breen, G., Collier, D., and Vallada, H. (2006) Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta gene variants and retrospectively scored response to lithium prophylaxis in bipolar disorder Neurosci. Lett. 403, 288-293
47. Manchia, M., Congiu, D., Squassina, A., Lampus, S., Ardau, R., Chillotti, C., Severino, G., and Del Zompo, M. (2009) No association between lithium full responders and the DRD1, DRD2, DRD3, DAT1, 5-HTTLPR and HTR2A genes in a Sardinian sample Psychiatry Res. 169, 164-166
48. Serretti, A., Lilli, R., Lorenzi, C., Gasperini, M., and Smeraldi, E. (1999) Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders J. Psychiatr. Res. 33, 371-377
49. Severino, G., Congiu, D., Serreli, C., De Lisa, R., Chillotti, C., Del Zompo, M., and Piccardi, M. P. (2005) A48G polymorphism in the D1 receptor genes associated with bipolar I disorder Am. J. Med. Genet., Part B 134B, 37-38
50. Rybakowski, J. K., Dmitrzak-Weglarz, M., and Suwalska, A. (2009) Dopamine D1 receptor gene polymorphism is associated with prophylactic lithium response in bipolar disorder Pharmacopsychiatry 42, 20-22
51. Szczepankiewicz, A., Skibinska, M., Suwalska, A., Hauser, J., and Rybakowski, J. K. (2009) No association of three GRIN2B polymorphisms with lithium response in bipolar patients Pharmacol. Rep. 61, 448-452
52. Szczepankiewicz, A., Rybakowski, J. K., Skibinska, M., Dmitrzak-Weglarz, M., Leszczynska-Rodziewicz, A., Wilkosc, M., and Hauser, J. (2009) FYN kinase gene: another glutamatergic gene associated with bipolar disorder? Neuropsychobiology 59, 178-183
53. Szczepankiewicz, A., Skibinska, M., Suwalska, A., Hauser, J., and Rybakowski, J. K. (2009) The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients Hum. Psychopharmacol. 24, 287-291
54. Harwood, A. J. (2005) Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited Mol. Psychiatry 10, 117-126
55. Steen, V. M., Løvlie, R., Osher, Y., Belmaker, R. H., Berle, J. O., and Gulbrandsen, A. K. (1998) The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness Pharmacogenetics 8, 259-268
56. Bremer, T., Diamond, C., McKinney, R., Shehktman, T., Barrett, T. B., Herold, C., and Kelsoe, J. R. (2007) The pharmacogenetics of lithium response depends upon clinical co-morbidity Mol. Diagn. Ther. 11, 161-170
57. Dimitrova, A., Milanova, V., Krastev, S., Nikolov, I., Toncheva, D., Owen, M. J., and Kirov, G. (2005) Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment Pharmacogenomics J. 5, 35-41
58. Manchia, M., Squassina, A., Congiu, D., Chillotti, C., Ardau, R., Severino, G., and Del Zompo, M. (2009) Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patients Neurosci. Lett. 467, 67-71
59. Mamdani, F., Alda, M., Grof, P., Young, L. T., Rouleau, G., and Turecki, G. (2008) Lithium response and genetic variation in the CREB family of genes Am. J. Med. Genet., Part B 147B, 500-504
60. Alda, M., Shao, L., Wang, J. F., Lopez de Lara, C., Jaitovich-Groisman, I., Lebel, V., Sun, X., Duffy, A., Grof, P., Rouleau, G. A., Turecki, G., and Young, L. T. (2013) Alterations in phosphorylated cAMP response element-binding protein (pCREB) signaling: an endophenotype of lithium-responsive bipolar disorder? Bipolar Disord. 15, 824-831
61. Gould, T. D. and Manji, H. K. (2005) Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs Neuropsychopharmacology 30, 1223-1237
62. Benedetti, F., Serretti, A., Pontigia, A., Bernasconi, A., Lorenzi, C., Colombo, C., and Smeraldi, E. (2005) Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta- 50T/C SNP Neurosci. Lett. 376, 51-55
63. Szczepankiewicz, A., Rybakowski, J. K., Suwalska, A., Skibinska, M., Leszczynska-Rodziewicz, A., Dmitrzak-Weglarz, M., Czerski, P. M., and Hauser, J. (2006) Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients World J. Biol. Psychiatry 7, 158-161
64. Campos-de-Sousa, S., Guindalini, C., Tondo, L., Munro, J., Osborne, S., Floris, G., Pedrazzoli, M., Tufik, S., Breen, G., and Collier, D. (2010) Nuclear receptor rev-erb-(alpha) circadian gene variants and lithium carbonate prophylaxis in bipolar affective disorder J. Biol. Rhythms 25, 132-137
65. McCarthy, M. J., Nievergelt, C. M., Shenkhtman, T., Kripke, D. F., Welsh, D. K., and Kelsoe, J. R. (2011) Functional genetic variation in the Rev-Erbα pathway and lithium response in the treatment of bipolar disorder Genes Brain Behav. 10, 852-861
66. Rybakowski, J. K., Dmitrzak-Weglarz, M., Kliwicki, S., and Hauser, J. (2014) Polymorphism of circadian clock genes and lithium response Bipolar Disord. 16, 151-158
67. Rybakowski, J. K., Skibinska, M., Leszczynska-Rodziewicz, A., Kaczmarek, L., and Hauser, J. (2009) Matrix metalloproteinase-9 (MMP-9) gene and bipolar mood disorder NeuroMol. Med. 11, 128-132
68. Rybakowski, J. K., Skibinska, M., Suwalska, A., Leszczynska-Rodziewicz, A., Kaczmarek, L., and Hauser, J. (2011) Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene and response to lithium prophylaxis in bipolar patients Hum. Psychopharmacol. 26, 168-171
69. Szczepankiewicz, A., Rybakowski, J. K., Suwalska, A., and Hauser, J. (2011) Glucocorticoid receptor polymorphism is associated with lithium response in bipolar patients Neuroendocrinol. Lett. 32, 545-551
70. Ceulemans, S., De Zutter, S., Heyrman, L., Norrback, K. F., Nordin, A., Nilsson, L. G., Adolfsson, R., Del-Favero, J., and Claes, S. (2011) Evidence for the involvement of the glucocorticoid receptor gene in bipolar disorder in an isolated northern Swedish population Bipolar Disord. 13, 614-623
71. Masui, T., Hashimoto, R., Kusumi, I., Suzuki, K., Tanaka, T., Nakagawa, S., Suzuki, T., Iwata, N., Ozaki, N., Kato, T., Takeda, M., Kunugi, H., and Koyama, T. (2008) A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 204-208
72. Masui, T., Hashimoto, R., Kusumi, I., Suzuki, K., Tanaka, T., Nakagawa, S., Kunugi, H., and Koyama, T. (2006) A possible association between the -116C/G single nucleotide polymorphism of the XBP1 gene and lithium prophylaxis in bipolar disorder Int. J. Neuropsychopharmacol. 9, 83-88
73. Hashimoto, R., Okada, T., Kato, T., Kosuga, A., Tatsumi, M., Kamijima, K., and Kunugi, H. (2005) The breakpoint cluster region gene on chromosome 22q11 is associated with bipolar disorder Biol. Psychiatry 57, 1097-1102
74. Kakiuchi, C., Iwamoto, K., Ishiwata, M. M., Bundo, M., Kasahara, T., Kusumi, I., Tsujita, T., Okazaki, Y., Nanko, S., Kunugi, H., Sasaki, T., and Kato, T. (2003) Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder Nat. Genet. 35, 171-175
75. Silberberg, G., Levit, A., Collier, D., St. Clair, D., Munro, J., Kerwin, R. W., Tondo, L., Floris, G., Breen, G., and Navon, R. (2008) Stargazin involvement with bipolar disorder and response to lithium treatment Pharmacogenetics Genomics 18, 403-412
76. Sears, C., Markie, D., Olds, R., and Fitches, A. (2011) Evidence of associations between bipolar disorder and the brain-derived neurotrophic factor (BDNF) gene Bipolar Disord. 13, 630-637
77. Rybakowski, J. K., Suwalska, A., Skibinska, M., Szczepankiewicz, A., Leszczynska-Rodziewicz, A., Permoda, A., Czerski, P. M., and Hauser, J. (2005) Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene Pharmacopsychiatry 38, 166-170
78. Dmitrzak-Weglarz, M., Rybakowski, J. K., Suwalska, A., Skibinska, M., Leszczynska-Rodziewicz, A., Szczepankiewicz, A., and Hauser, J. (2008) Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients Pharmacogenomics 9, 1595-1603
79. Savitz, J., van der Merve, L., and Ramesar, R. (2008) Personality endophenotypes for bipolar affective disorder: a family-based genetic association analysis Genes, Brain Behav. 7, 869-876
80. Rybakowski, J. K., Suwalska, A., Skibinska, M., Dmitrzak-Weglarz, M., Leszczynska-Rodziewicz, A., and Hauser, J. (2007) Response to lithium prophylaxis: Interaction between serotonin transporter and BDNF genes Am. J. Med. Genet., Part B 144B, 820-823
81. Masui, T., Hashimoto, R., Kusumi, I., Suzuki, K., Tanaka, T., Nakagawa, S., Suzuki, T., Iwata, N., Ozaki, N., Kato, T., Kunugi, H., and Koyama, T. (2006) Lithium response and Val66Met polymorphism of the brain derived neurotrophic factor gene in Japanese patients with bipolar disorder Psychiatr. Genet. 16, 49-50
82. Yazlovitskaya, E. M., Edwards, E., Thotala, D., Fu, A., Osusky, K. L., Whetsell, W. O., Jr., Boone, B., Shinohara, E. T., and Hallahan, D. E. (2006) Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation Cancer Res. 66, 11179-11186
83. Nocjar, C., Hammonds, M. D., and Shim, S. S. (2007) Chronic lithium treatment magnifies learning in rats Neuroscience 150, 774-788
84. Mora, E., Portella, M. J., Forcada, I., Vieta, E., and Mur, M. (2013) Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: a 6-year follow-up study Psychol. Med. 43, 1187-1196
85. Rybakowski, J. K., Permoda-Osip, A., and Borkowska, A. (2009) Response to prophylactic lithium in bipolar disorder may be associated with a preservation of executive cognitive functions Eur. Neuropsychopharmacol. 19, 791-795
86. Rybakowski, J. K. and Suwalska, A. (2010) Excellent lithium responders have normal cognitive functions and plasma BDNF levels Int. J. Neuropsychopharmacol. 13, 617-622
87. Kapczinski, F., Fernandes, B. S., Kauer-Sant'Anna, M., Gama, C. S., Yatham, L. N., and Berk, M. (2009) The concept of staging in bipolar disorder: the role of BDNF and TNF-alpha as biomarkers Acta Neuropsychiatr. 21, 272-274
88. Zubieta, J. K., Huguelet, P., O'Neil, R. L., and Giordani, B. J. (2001) Cognitive function in euthymic bipolar I disorder Psychiatry Res. 102, 9-20
89. Cavanagh, J. T., Van Beck, M., Muir, W., and Blackwood, D. H. (2002) Case-control study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania Br. J. Psychiatry 180, 320-326
90. Dickerson, F. B., Boronow, J. J., Stallings, C., Origoni, A. E., Cole, S., Krivogorsky, B., and Yolken, R. H. (2004) Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder Biol. Psychiatry 55, 588-593
91. Rybakowski, J. K. and Amsterdam, J. D. (1991) Lithium prophylaxis and recurrent labial herpes infections Lithium 2, 43-47
92. Perlis, R. H., Purcell, S., Fagerness, J., Kirby, A., Petryshen, T. L., Fan, J., and Sklar, P. (2008) Family-based association study of lithium-related and other candidate genes in bipolar disorder Arch. Gen. Psychiatry 65, 53-61
93. Baum, A. E., Akula, N., Cabanero, M., Cardona, I., Corona, W., Klemens, B., Schulze, T. G., Cichon, S., Rietschel, M., Nöthen, M. M., Georgi, A., Schumacher, J., Schwarz, M., Abou Jamra, R., Höfels, S., Propping, P., Satagopan, J., Detera-Wadleigh, S. D., Hardy, J., and McMahon, F. J. (2008) A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder Mol. Psychiatry 13, 197-207
94. Perlis, R. H., Smoller, J. W., Ferreira, M. A. R., McQuillin, A., Bass, N., Lawrence, J., Sachs, G. S., Nimgaonkar, V., Scolnick, E. M., Gurling, H., Sklar, P., and Purcell, S. (2009) A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder Am. J. Psychiatry 166, 718-725
95. Squassina, A., Manchia, M., Borg, J., Congiu, D., Costa, M., Georgitsi, M., Chillotti, C., Ardau, R., Mitropoulos, K., Severino, G., Del Zompo, M., and Patrinos, G. P. (2011) Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder Pharmacogenomics 12, 1559-1569
96. Chen, C. H., Lee, C. S., Lee, M. T., Ouyang, W. C., Chen, C. C., Chong, M. Y., Wu, J. Y., Tan, H. K., Lee, Y. C., Chuo, L. J., Chiu, N. Y., Tsang, H. Y., Chang, T. J., Lung, F. W., Chiu, C. H., Chang, C. H., Chen, Y. S., Hou, Y. M., Chen, C. C., Lai, T. J., Tung, C. L., Chen, C. Y., Lane, H. Y., Su, T. P., Feng, J., Lin, J. J., Chang, C. J., Teng, P. R., Liu, C. Y., Chen, C. K., Liu, I. C., Chen, J. J., Lu, T., Fan, C. C., Wu, C. K., Li, C. F., Wang, K. H., Wu, L. S., Peng, H. L., Chang, C. P., Lu, L. S., Chen, Y. T., Cheng, A. T., and Taiwan Bipolar Consortium (2014) Variant GADL1 and response to lithium therapy in bipolar I disorder N. Engl. J. Med. 370, 117-128
97. Schulze, T. G., Alda, M., Adli, M., Akula, N., Ardau, R., Bui, E. T., Chillotti, C., Cichon, S., Czerski, P., Del Zompo, M., Detera-Wadleigh, S. D., Grof, P., Gruber, O., Hashimoto, R., Hauser, J., Hoban, R., Iwata, N., Kassem, L., Kato, T., Kittel-Schneider, S., Kliwicki, S., Kelsoe, J. R., Kusumi, I., Laje, G., Leckband, S. G., Manchia, M., Macqueen, G., Masui, T., Ozaki, N., Perlis, R. H., Pfennig, A., Piccardi, P., Richardson, S., Rouleau, G., Reif, A., Rybakowski, J. K., Sasse, J., Schumacher, J., Severino, G., Smoller, J. W., Squassina, A., Turecki, G., Young, L. T., Yoshikawa, T., Bauer, M., and McMahon, F. J. (2010) The International Consortium on Lithium Genetics (ConLiGen): An initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment Neuropsychobiology 62, 72-78
98. Manchia, M., Adli, M., Akula, N., Ardau, R., Aubry, J. M., Backlund, L., Banzato, C. E., Baune, B. T., Bellivier, F., Bengesser, S., Biernacka, J. M., Brichant-Petitjean, C., Bui, E., Calkin, C. V., Cheng, A. T., Chillotti, C., Cichon, S., Clark, S., Czerski, P. M., Dantas, C., Zompo, M. D., Depaulo, J. R., Detera-Wadleigh, S. D., Etain, B., Falkai, P., Frisén, L., Frye, M. A., Fullerton, J., Gard, S., Garnham, J., Goes, F. S., Grof, P., Gruber, O., Hashimoto, R., Hauser, J., Heilbronner, U., Hoban, R., Hou, L., Jamain, S., Kahn, J. P., Kassem, L., Kato, T., Kelsoe, J. R., Kittel-Schneider, S., Kliwicki, S., Kuo, P. H., Kusumi, I., Laje, G., Lavebratt, C., Leboyer, M., Leckband, S. G., López Jaramillo, C. A., Maj, M., Malafosse, A., Martinsson, L., Masui, T., Mitchell, P. B., Mondimore, F., Monteleone, P., Nallet, A., Neuner, M., Novák, T., O'Donovan, C., Osby, U., Ozaki, N., Perlis, R. H., Pfennig, A., Potash, J. B., Reich-Erkelenz, D., Reif, A., Reininghaus, E., Richardson, S., Rouleau, G. A., Rybakowski, J. K., Schalling, M., Schofield, P. R., Schubert, O. K., Schweizer, B., Seemüller, F., Grigoroiu-Serbanescu, M., Severino, G., Seymour, L. R., Slaney, C., Smoller, J. W., Squassina, A., Stamm, T., Steele, J., Stopkova, P., Tighe, S. K., Tortorella, A., Turecki, G., Wray, N. R., Wright, A., Zandi, P. P., Zilles, D., Bauer, M., Rietschel, M., McMahon, F. J., Schulze, T. G., and Alda, M. (2013) Assessment of response to lithium maintenance treatment in bipolar disorder: A Consortium on Lithium Genetics (ConLiGen) report PLoS One 8, e65636
99. Schulze, T. The Consortium on Lithium Genetics (ConLiGen) genome-wide association studies of lithium response phenotypes in bipolar disorder. (2012) CINP Congress, Stockholm, 3-7 June, Abstract book, p 36.
100. The Consortium of Lithium Genetics (ConLiGen); No association between GADL1 markers and lithium response in Asians with bipolar disorders. New Engl. J. Med. 2014, (370) in press